Cardica plans to offer 1.5 million shares of its common stock for sale by Cardica and 2,579,795 shares of its common stock for sale by a selling stockholder in an underwritten public offering.
Subscribe to our email newsletter
Cardica, a provider of automated anastomosis systems for coronary artery bypass graft surgery, will not receive any proceeds from sales of shares made by the selling stockholder and expects to grant the underwriters a 30-day option to purchase up to an additional 611,969 shares of common stock from Cardica to cover over-allotments, if any.
These shares will be issued pursuant to a currently effective shelf registration statement.
William Blair & Company is acting as the sole book-running manager of the offering. Allen & Company, Needham & Company and Merriman Curhan Ford & Co will act as co-managers of the offering.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.